Y. Robert Li - Cardiovascular Diseases: From Molecular Pharmacology to Evidence–Based Therapeutics
-15%

Cardiovascular Diseases: From Molecular Pharmacology to Evidence–Based Therapeutics

Y. Robert Li

ISBN: 9780470915370
Vydavatelství: Wiley
Rok vydání: 2015
Vazba: Hardback
Počet stran: 504
Dostupnost: Na objednávku

Původní cena: 3 466 Kč
Výstavní cena: 2 946 Kč(t.j. po slevě 15%)
(Cena je uvedena včetně 10% DPH)
Katalogová cena: 83.5 GBP

Nárok na dopravu zdarma
Přidat do wishlistu
Zpět Tisknout
Koupit
Even though there has been improvement in treatment and significant reduction in mortality rate, cardiovascular disease remains one of the leading causes of death around the world. Drug therapy continues to rank high as a way to manage heart disease making cardiovascular pharmacology a key part of medical education and drug development research. This book addresses the needs of these students and researchers by systematically integrating essentials, advances, and clinical correlations for cardiovascular drugs. The author, who has over two decades of experience teaching this topic, covers both the fundamentals and most recent advances in the pharmacology of cardiovascular drugs, as well as their integrated applications in the management of individual cardiovascular diseases. In addition, the text presents evidence–based pharmacotherapeutics in the management of common cardiovascular diseases and conditions that include dyslipidemias, hypertension, ischemic heart disease, heart failure, cardiac arrhythmias, and ischemic stroke. Written in an accessible style and consistent format, the book covers both the fundamentals and advances in the pharmacology of cardiovascular drugs, as well as their integrated applications in the management of individual cardiovascular diseases.     Blends basic and clinical sciences needed to effectively understand and treat cardiovascular diseases     Facilitates understanding of drug action and mechanism by covering physiology / pathophysiology and pharmacology     Includes guidelines and algorithms for pharmacotherapeutic management of cardiovascular diseases     Uses case presentations and study questions to enhance understanding of the material     Serves as a resource for pharmaceutical and medical students and researchers interested in cardiovascular issues